Cambridge Investment Research Advisors’s BowFlex Inc. BFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-25,899
Closed -$20K 3424
2023
Q4
$20K Sell
25,899
-700
-3% -$477 ﹤0.01% 3144
2023
Q3
$23K Buy
26,599
+1,481
+6% +$1.46K ﹤0.01% 3078
2023
Q2
$31K Hold
25,118
﹤0.01% 3110
2023
Q1
$34K Sell
25,118
-425
-2% -$703 ﹤0.01% 3074
2022
Q4
$39K Sell
25,543
-1,800
-7% -$2.86K ﹤0.01% 3007
2022
Q3
$45K Buy
27,343
+12,000
+78% +$24.2K ﹤0.01% 2950
2022
Q2
$27K Buy
15,343
+3,450
+29% +$9.54K ﹤0.01% 2984
2022
Q1
$49K Buy
11,893
+835
+8% +$4.15K ﹤0.01% 3077
2021
Q4
$68K Sell
11,058
-6,525
-37% -$54.1K ﹤0.01% 3073
2021
Q3
$164K Buy
17,583
+5,928
+51% +$76.1K ﹤0.01% 2859
2021
Q2
$196K Buy
+11,655
New +$196K ﹤0.01% 2845
2020
Q2
Sell
-15,400
Closed -$40K 2528
2020
Q1
$40K Buy
15,400
+400
+3% +$1.09K ﹤0.01% 2198
2019
Q4
$26K Hold
15,000
﹤0.01% 2382
2019
Q3
$20K Buy
+15,000
New +$23.5K ﹤0.01% 2322

Other funds holding BFX

Cambridge Investment Research Advisors's BFX Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of BowFlex Inc. (BFX) in Q1 2024, closing a stake of 25,899 shares — an estimated $20K sold.

Cambridge Investment Research Advisors first reported a position in BFX in Q3 2019 and held it in 14 quarters. The position peaked at $196K in Q2 2021. 6 funds tracked by Wall St. Rank hold BFX as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining BowFlex Inc. position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 25,899 BowFlex Inc. shares in Q1 2024, an estimated $20K.
  • Cambridge Investment Research Advisors first reported a position in BowFlex Inc. in Q3 2019 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's BowFlex Inc. position peaked at $196K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held BowFlex Inc. as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.